Chromium Picolinate for the Treatment of Metabolic Syndrome

NCT00128154 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Metabolic Syndrome X
Prediabetic State
Insulin Resistance
Obesity
Metabolic Diseases

Interventions

DRUG: Chromium picolinate

Sponsor

National Center for Complementary and Integrative Health (NCCIH)